Clinical Trial Update: GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery [NA]

View source ↗

Summary

A completed clinical trial comparing GATT-Patch to SURGICEL Original in minimally invasive liver and gallbladder surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gallbladder Diseases
• Liver Diseases

Drugs mentioned

• GATT-Patch
• Surgicel Original (oxidized regenerated cellulose hemostat)

Snippet

Sponsor: GATT Technologies BV | Conditions: Intraoperative Bleeding, Liver Diseases | NA | Status: COMPLETED